Compile Data Set for Download or QSAR
Report error Found 701 for UniProtKB: P01130
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052676(N-[3-(1H-Benzoimidazol-2-yl)-4-methyl-phenyl]-3-cy...)
Affinity DataEC50:  1.30E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052677(N-(2-Cyclohexyl-ethyl)-3-(4-hydroxy-benzoylamino)-...)
Affinity DataEC50:  2.00E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052678(3-Cyclohexyl-N-[4-methyl-3-(5-methyl-1H-benzoimida...)
Affinity DataEC50:  1.30E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052679(N-[5-(3-Cyclohexyl-propionylamino)-2-methyl-phenyl...)
Affinity DataEC50:  2.00E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052681(N-[3-((Z)-2-Benzo[1,3]dioxol-5-yl-2-cyano-vinyl)-4...)
Affinity DataEC50:  700nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052682(3-Cyclohexyl-N-[3-(5-hydroxy-1H-benzoimidazol-2-yl...)
Affinity DataEC50:  700nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052683(N-[3-((Z)-2-Cyano-2-pyridin-3-yl-vinyl)-4-methyl-p...)
Affinity DataEC50:  1.00E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052680(N-[5-(3-Cyclohexyl-propionylamino)-2-methyl-phenyl...)
Affinity DataEC50:  1.70E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052685(4-Amino-N-[5-(3-cyclohexyl-propionylamino)-2-methy...)
Affinity DataEC50:  3.80E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052684(N-[5-(3-Cyclohexyl-propionylamino)-2-methyl-phenyl...)
Affinity DataEC50:  7.60E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052688(N-[5-(3-Cyclohexyl-propionylamino)-2-methyl-phenyl...)
Affinity DataEC50:  2.00E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052686(N-{3-[(Benzo[1,3]dioxol-5-ylmethyl)-amino]-4-methy...)
Affinity DataEC50:  600nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052687(N-[5-(3-Cyclohexyl-propionylamino)-2-methyl-phenyl...)
Affinity DataEC50:  1.20E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052690(Acetic acid 4-[5-(3-cyclohexyl-propionylamino)-2-m...)
Affinity DataEC50:  2.50E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052689(N-[5-(4-Cyclohexyl-butyrylamino)-2-methyl-phenyl]-...)
Affinity DataEC50:  4.00E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052691(N-[5-(4-Cyclohexyl-butyryl)-2-methyl-phenyl]-nicot...)
Affinity DataEC50:  2.00E+3nMAssay Description:Concentration at which one-half the maximum Low density lipoprotein receptor up-regulation is observed in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetLow-density lipoprotein receptor(Human)
RhôNe-Poulenc Rorer

Curated by ChEMBL
LigandPNGBDBM50052692(5-(3-Cyclohexyl-propionylamino)-N-(4-hydroxy-pheny...)
Affinity DataEC50:  7.00E+3nMAssay Description:Concentration at which one-half of the maximum Low density lipoprotein receptor is upregulated in HepG2 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
LigandPNGBDBM586102(US11530244, Compound 004)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586103(US11530244, Compound 005)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586105(US11530244, Compound 007)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586108(US11530244, Compound 010)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586117(US11530244, Compound 034)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586118(US11530244, Compound 035)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586119(US11530244, Compound 036)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586121(US11530244, Compound 038)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586128(US11530244, Compound 046)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586133(US11530244, Compound 051)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586136(US11530244, Compound 054)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586140(US11530244, Compound 058)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586147(US11530244, Compound 065)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586148(US11530244, Compound 066)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586149(US11530244, Compound 067)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586150(US11530244, Compound 068)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586157(US11530244, Compound 130)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586164(US11530244, Compound 146)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586169(US11530244, Compound 152)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586175(US11530244, Compound 171)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586179(US11530244, Compound 184)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586180(US11530244, Compound 185)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586200(US11530244, Compound 223)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM50554744(CHEMBL4759663 | US11530244, Compound 248)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586214(US11530244, Compound 275)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586215(US11530244, Compound 276)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586216(US11530244, Compound 277)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586217(US11530244, Compound 281)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586223(US11530244, Compound 293)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586225(US11530244, Compound 296)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586236(US11530244, Compound 318)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586242(US11530244, Compound 327)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

LigandPNGBDBM586243(US11530244, Compound 328)
Affinity DataIC50: 50nMAssay Description:A set of cyclic polypeptides were identified to inhibit the interaction between human PCSK9 and human LDLR. Each polypeptide has an N-terminal amino ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/17/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 701 total ) | Next | Last >>
Jump to: